Industrivarden AB operates within the Investors sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Industrivarden AB with three other
financial institutions in Europe:
BB Biotech AG
sales of 240.87 million Swiss Francs [US$248.32 million]
of which 100%
was Investing & Related Activity),
Aforti Holding SA
(1.04 billion Polish New Zlotys [US$244.47 million]
based in GERMANY
(372.80 million Euros [US$401.73 million]
During the year ended December of 2019, sales at
Industrivarden AB were SEK 4.09 billion (US$402.34 million).
increase of 8.7%
versus 2018, when the company's sales were SEK 3.76 billion.